296
Participants
Start Date
June 30, 2009
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
AZD 8529
40mg oral daily capsule administered as a single dose in the morning for 28 days
Risperidone
4mg (2mg on Day 1) oral daily capsule administered as a single dose in the evening for 28 days
Placebo to match AZD8529
Placebo to match AZD8529 administered as a daily capsule in the morning for 28 days during the treatment period and also during the 3-7 day washout or run-in period
Placebo to match risperidone
Placebo to match risperidone administered as a daily capsule in the evening for 28 days during the treatment period and also during the 3-7 day washout or run-in period
Research Site, Garden Grove
Research Site, Glendale
Research Site, Rockville
Lead Sponsor
AstraZeneca
INDUSTRY